Prognostic impact of MRP3 expression using quartiles and thirds as cutoffs for high and low expression in all patients (n = 103)
. | Low expression of MRP3 . | . | High expression of MRP3 . | . | . | ||
|---|---|---|---|---|---|---|---|
| Percentile used as cutoff . | Overall survival after 10 years, % . | Standard error, % . | Overall survival after 10 years, % . | Standard error, % . | Log-rank test, P . | ||
| 25 | 64 | 11 | 55 | 6 | .14 | ||
| 33 | 66 | 9 | 52 | 6 | .04 | ||
| 50 | 62 | 7 | 52 | 7 | .05 | ||
| 66 | 63 | 6 | 46 | 9 | .009 | ||
| 75 | 64 | 6 | 38 | 10 | .002 | ||
. | Low expression of MRP3 . | . | High expression of MRP3 . | . | . | ||
|---|---|---|---|---|---|---|---|
| Percentile used as cutoff . | Overall survival after 10 years, % . | Standard error, % . | Overall survival after 10 years, % . | Standard error, % . | Log-rank test, P . | ||
| 25 | 64 | 11 | 55 | 6 | .14 | ||
| 33 | 66 | 9 | 52 | 6 | .04 | ||
| 50 | 62 | 7 | 52 | 7 | .05 | ||
| 66 | 63 | 6 | 46 | 9 | .009 | ||
| 75 | 64 | 6 | 38 | 10 | .002 | ||